Cargando…

Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study

BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Oguntunde, Olugbenga, Charyeva, Zulfiya, Cannon, Molly, Sambisa, William, Orobaton, Nosakhare, Kabo, Ibrahim A, Shoretire, Kamil, Danladi, Saba’atu E, Lawal, Nurudeen, Sadauki, Habib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451740/
https://www.ncbi.nlm.nih.gov/pubmed/26037906
http://dx.doi.org/10.1186/s12884-015-0554-8
_version_ 1782374188053430272
author Oguntunde, Olugbenga
Charyeva, Zulfiya
Cannon, Molly
Sambisa, William
Orobaton, Nosakhare
Kabo, Ibrahim A
Shoretire, Kamil
Danladi, Saba’atu E
Lawal, Nurudeen
Sadauki, Habib
author_facet Oguntunde, Olugbenga
Charyeva, Zulfiya
Cannon, Molly
Sambisa, William
Orobaton, Nosakhare
Kabo, Ibrahim A
Shoretire, Kamil
Danladi, Saba’atu E
Lawal, Nurudeen
Sadauki, Habib
author_sort Oguntunde, Olugbenga
collection PubMed
description BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. METHODS: Data were collected from 80 health facilities using a cross-sectional, mixed method (quantitative and qualitative) design. We assessed health facility readiness to manage PE/E and use MgSO(4) as the drug of choice, through provider interviews, in-depth interviews with facility managers and an inventory of equipment and supply in facilities. Bivariate and qualitative data analyses were performed to isolate the principal enabling factors and barriers to the management of PE/E and use of MgSO(4). RESULTS: The majority of health facility providers correctly mentioned MgSO(4) as the drug of choice for the prevention and termination of convulsions in severe PE/E (65 %). Sixty-four percent of the health facilities had service registers available. About 45 % of providers had been trained on the use of MgSO(4) for the management of PE/E. Regarding providers’ practices, 45 % of respondents indicated that MgSO(4) was used to prevent and treat convulsions in severe PE/E in their facilities. Barriers to management of PE/E included inadequate numbers of skilled providers, frequent shortages of MgSO(4), lack of essential equipment and supplies, irregular supply of electricity and water, and non-availability of guidelines and clinical protocols at the health facilities. Technical support to providers was inadequate. CONCLUSION: The study revealed that a constellation of factors adversely affect the management of PE/E and especially the use of MgSO(4) by service providers. Efforts to improve the management of PE/E in facilities should include integrated programs that substantially improve provider and facility readiness to manage PE/E for better maternal and newborn health outcomes in Northern Nigeria.
format Online
Article
Text
id pubmed-4451740
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44517402015-06-03 Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study Oguntunde, Olugbenga Charyeva, Zulfiya Cannon, Molly Sambisa, William Orobaton, Nosakhare Kabo, Ibrahim A Shoretire, Kamil Danladi, Saba’atu E Lawal, Nurudeen Sadauki, Habib BMC Pregnancy Childbirth Research Article BACKGROUND: Eclampsia remains a major cause of perinatal and maternal morbidity and mortality worldwide. We examined facilitators and barriers to the use of magnesium sulphate (MgSO(4)) in the management of pre-eclampsia/eclampsia (PE/E) in health facilities in Bauchi and Sokoto States in Nigeria. METHODS: Data were collected from 80 health facilities using a cross-sectional, mixed method (quantitative and qualitative) design. We assessed health facility readiness to manage PE/E and use MgSO(4) as the drug of choice, through provider interviews, in-depth interviews with facility managers and an inventory of equipment and supply in facilities. Bivariate and qualitative data analyses were performed to isolate the principal enabling factors and barriers to the management of PE/E and use of MgSO(4). RESULTS: The majority of health facility providers correctly mentioned MgSO(4) as the drug of choice for the prevention and termination of convulsions in severe PE/E (65 %). Sixty-four percent of the health facilities had service registers available. About 45 % of providers had been trained on the use of MgSO(4) for the management of PE/E. Regarding providers’ practices, 45 % of respondents indicated that MgSO(4) was used to prevent and treat convulsions in severe PE/E in their facilities. Barriers to management of PE/E included inadequate numbers of skilled providers, frequent shortages of MgSO(4), lack of essential equipment and supplies, irregular supply of electricity and water, and non-availability of guidelines and clinical protocols at the health facilities. Technical support to providers was inadequate. CONCLUSION: The study revealed that a constellation of factors adversely affect the management of PE/E and especially the use of MgSO(4) by service providers. Efforts to improve the management of PE/E in facilities should include integrated programs that substantially improve provider and facility readiness to manage PE/E for better maternal and newborn health outcomes in Northern Nigeria. BioMed Central 2015-06-03 /pmc/articles/PMC4451740/ /pubmed/26037906 http://dx.doi.org/10.1186/s12884-015-0554-8 Text en © Oguntunde et al. 2015
spellingShingle Research Article
Oguntunde, Olugbenga
Charyeva, Zulfiya
Cannon, Molly
Sambisa, William
Orobaton, Nosakhare
Kabo, Ibrahim A
Shoretire, Kamil
Danladi, Saba’atu E
Lawal, Nurudeen
Sadauki, Habib
Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title_full Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title_fullStr Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title_full_unstemmed Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title_short Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study
title_sort factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in northern nigeria: a mixed methods study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451740/
https://www.ncbi.nlm.nih.gov/pubmed/26037906
http://dx.doi.org/10.1186/s12884-015-0554-8
work_keys_str_mv AT oguntundeolugbenga factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT charyevazulfiya factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT cannonmolly factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT sambisawilliam factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT orobatonnosakhare factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT kaboibrahima factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT shoretirekamil factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT danladisabaatue factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT lawalnurudeen factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy
AT sadaukihabib factorsinfluencingtheuseofmagnesiumsulphateinpreeclampsiaeclampsiamanagementinhealthfacilitiesinnorthernnigeriaamixedmethodsstudy